ql1604
Showing 1 - 5 of 5
Advanced Solid Tumor Trial in Nanchang, Shanghai (QL1604)
Active, not recruiting
- Advanced Solid Tumor
- QL1604
-
Nanchang, China
- +1 more
Mar 24, 2023
Advanced Liver Cancer Trial in Chengdu (QL1706, QL1604, Bevacizumab)
Recruiting
- Advanced Liver Cancer
- QL1706
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Nov 1, 2022
Cervical Cancer Trial in Guangzhou (QL1604, Paclitaxel injection, Cisplatin/Carboplatin)
Unknown status
- Cervical Cancer
- QL1604
- +2 more
-
Guangzhou, Guangzhou, ChinaSun Yat-Sen University Cancer Center
Apr 25, 2021
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Shanghai (QL1604, Nab-paclitaxel, Paclitaxel)
Not yet recruiting
- Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
- QL1604
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Cancer Hospital
Jun 15, 2020
Advanced Malignant Tumor Trial in Shanghai, Chengdu (QL1604)
Unknown status
- Advanced Malignant Tumor
- QL1604
-
Shanghai, Shanghai, China
- +1 more
Mar 26, 2020